Skip to main content

UBS Group AG

Position in DNLI — Denali Therapeutics Inc.

CIK 1610520 ZURICH, V8

Position in DNLI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$80,261,624
+$30,891,821 QoQ
Shares Held
3,120,592
+21.4% QoQ
Ownership
1.95%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#15
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,365,122 across 562 Biotechnology names. DNLI ranks #25 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNLI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $80,261,624 3,120,592
2026-03-31 $49,369,803 2,571,344
2025-12-31 $39,701,662 2,404,704
2025-09-30 $29,219,365 2,012,353
2025-06-30 $13,301,187 950,764
2025-03-31 $10,718,691 788,429
2024-12-31 $17,381,304 852,861
2024-09-30 $4,119,068 141,403
2024-06-30 $3,163,097 136,223
2024-03-31 $7,056,396 343,879
2023-12-31 $6,244,537 290,985
2023-09-30 $2,263,028 109,696
2023-06-30 $3,893,549 131,940
2023-03-31 $2,934,165 127,351
2022-12-31 $3,342,233 120,181
2022-09-30 $1,302,912 42,454
2022-06-30 $187,615 6,375
2022-03-31 $1,258,232 39,112
2021-12-31 $4,118,720 92,348
2021-09-30 $3,253,015 64,480
2021-06-30 $191,158 2,437
2021-03-31 $1,726,075 30,229
2020-12-31 $485,472 5,796
2020-09-30 $224,187 6,257
2020-06-30 $64,971 2,687
2020-03-31 $206,758 11,808